Clinical Trial of High-Dose Pegylated-Interferon-Alfa-2b Combined With Phototherapy in Advanced Stage Mycosis Fungoides.
Adult
Aged
Combined Modality Therapy
/ adverse effects
Dose-Response Relationship, Drug
Feasibility Studies
Female
Humans
Interferon alpha-2
/ administration & dosage
Interferon-alpha
/ administration & dosage
Male
Middle Aged
Mycosis Fungoides
/ diagnosis
Neoplasm Staging
PUVA Therapy
/ adverse effects
Pilot Projects
Polyethylene Glycols
/ administration & dosage
Recombinant Proteins
/ administration & dosage
Skin Neoplasms
/ diagnosis
Treatment Outcome
Journal
Journal of drugs in dermatology : JDD
ISSN: 1545-9616
Titre abrégé: J Drugs Dermatol
Pays: United States
ID NLM: 101160020
Informations de publication
Date de publication:
01 03 2021
01 03 2021
Historique:
entrez:
8
3
2021
pubmed:
9
3
2021
medline:
9
7
2021
Statut:
ppublish
Résumé
The combination of Interferon-α-2b (IFN-α-2b) and phototherapy is highly effective in treating mycosis fungoides (MF) but side effects often lead to discontinuation of therapy.1.
Identifiants
pubmed: 33683074
pii: S1545961621P0349X
doi: 10.36849/JDD.5756
doi:
Substances chimiques
Interferon alpha-2
0
Interferon-alpha
0
Recombinant Proteins
0
Polyethylene Glycols
3WJQ0SDW1A
peginterferon alfa-2b
G8RGG88B68
Types de publication
Clinical Trial
Journal Article
Langues
eng
Sous-ensembles de citation
IM